Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 13:12:816481.
doi: 10.3389/fendo.2021.816481. eCollection 2021.

Editorial: The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication

Khalid Siddiqui  1 , Ernesto Maddaloni  2
Affiliations
Editorial

Editorial: The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication

Khalid Siddiqui et al. Front Endocrinol (Lausanne). .
No abstract available

Keywords: Alzheimer’s disease; complications; diabetes; heart failure; retinopathy; special issue.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication

Similar articles

See all similar articles

References

    1. Park K, Mima A, Li Q, Rask-Madsen C, He P, Mizutani K, et al. . Insulin Decreases Atherosclerosis by Inducing Endothelin Receptor B Expression. JCI Insight (2016) 1(6):e86574. doi: 10.1172/jci.insight.86574 - DOI - PMC - PubMed
    1. Maddaloni E, Pozzilli P. SMART Diabetes: The Way to Go (Safe and Multifactorial Approach to Reduce the Risk for Therapy in Diabetes). Endocrine (2014) 46:3–5. doi: 10.1007/s12020-013-0128-3 - DOI - PubMed
    1. Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global Trends in Diabetes Complications: A Review of Current Evidence. Diabetologia (2019) 62:3–16. doi: 10.1007/s00125-018-4711-2 - DOI - PubMed
    1. Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson A-M, Miftaraj M, et al. . Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med (2017) 376:1407–18. doi: 10.1056/NEJMoa1608664 - DOI - PubMed
    1. Patti G, Cavallari I, Andreotti F, Calabrò P, Cirillo P, Denas G, et al. . Prevention of Atherothrombotic Events in Patients With Diabetes Mellitus: From Antithrombotic Therapies to New-Generation Glucose-Lowering Drugs. Nat Rev Cardiol (2018) 16(2):113–30. doi: 10.1038/s41569-018-0080-2 - DOI - PMC - PubMed

Publication types

LinkOut - more resources